-
1.发明公开바실러스 속 ＣＭＢ Ｌ1 및 락토바실러스 속 ＣＭＢ 201의 혼합균주 및 이를 이용한 항암 및 면역증강용 식품 조성물 无效BACILLUS SP的新颖菌株 CMB L1，LACTOBACILLUS SP。 CMB201和使用两种菌株和发酵材料增加免疫力，抗肿瘤活性和纤维蛋白活性的食品添加剂
公开(公告)号：KR1020110035554A
公开(公告)日：2011-04-06
申请号：KR1020090093323
申请日：2009-09-30
Applicant: 전남대학교산학협력단
Abstract: PURPOSE: A mixture strain of Bacillus sp. CMB L1 and Lactobacillus sp. CMB201 is provided to be used as a microbial formulation. CONSTITUTION: A Bacillus sp. CMB L1(KCTC 18135) and Lactobacillus sp. CMB 201(KCTC 18136) are isolated from soybean paste and have thrombolysis activity and anticancer activity. A food composition for anticancer and immunity enhancement contains the Bacillus sp. CMB L1(KCTC 18135) and Lactobacillus sp. CMB 201(KCTC 18136) or culture thereof.
Abstract translation: 目的：芽孢杆菌属混合菌株 CMB L1和乳杆菌属 提供CMB201用作微生物制剂。 构成：芽孢杆菌 CMB L1（KCTC 18135）和Lactobacillus sp。 CMB 201（KCTC 18136）与大豆酱分离，具有溶栓活性和抗癌活性。 用于抗癌和免疫增强的食物组合物包含芽孢杆菌属（Bacillus sp。 CMB L1（KCTC 18135）和Lactobacillus sp。 CMB 201（KCTC 18136）或其培养物。
Search Results
1
records
(took 0.028 seconds)
